NASDAQ:EBIO
Delisted

Eleven Biotherapeutics Fund Price (Quote)

$3.29
+0 (+0%)
At Close: May 31, 2018

Range Low Price High Price Comment
30 days $2.52 $3.50 Thursday, 31st May 2018 EBIO stock ended at $3.29. During the day the stock fluctuated 0% from a day low at $3.29 to a day high of $3.29.
90 days $0.90 $3.50
52 weeks $0.620 $3.50

Historical Eleven Biotherapeutics prices

Date Open High Low Close Volume
Feb 19, 2016 $0.315 $0.315 $0.285 $0.300 443 700
Feb 18, 2016 $0.280 $0.320 $0.271 $0.320 1 370 900
Feb 17, 2016 $0.270 $0.310 $0.270 $0.290 847 000
Feb 16, 2016 $0.270 $0.290 $0.261 $0.280 214 600
Feb 12, 2016 $0.270 $0.290 $0.252 $0.270 633 800
Feb 11, 2016 $0.268 $0.270 $0.251 $0.270 230 800
Feb 10, 2016 $0.268 $0.280 $0.260 $0.270 211 800
Feb 09, 2016 $0.290 $0.290 $0.260 $0.260 193 700
Feb 08, 2016 $0.300 $0.300 $0.271 $0.280 228 200
Feb 05, 2016 $0.300 $0.309 $0.290 $0.300 590 900
Feb 04, 2016 $0.300 $0.310 $0.287 $0.300 515 700
Feb 03, 2016 $0.300 $0.310 $0.270 $0.300 554 600
Feb 02, 2016 $0.320 $0.330 $0.290 $0.310 577 300
Feb 01, 2016 $0.320 $0.330 $0.310 $0.320 677 100
Jan 29, 2016 $0.340 $0.340 $0.320 $0.320 337 400
Jan 28, 2016 $0.350 $0.362 $0.320 $0.340 497 200
Jan 27, 2016 $0.340 $0.399 $0.320 $0.360 1 179 100
Jan 26, 2016 $0.350 $0.370 $0.331 $0.350 633 800
Jan 25, 2016 $0.390 $0.400 $0.360 $0.370 914 200
Jan 22, 2016 $0.400 $0.407 $0.371 $0.390 796 900
Jan 21, 2016 $0.450 $0.450 $0.360 $0.370 1 831 000
Jan 20, 2016 $0.471 $0.500 $0.420 $0.450 1 285 900
Jan 19, 2016 $1.05 $1.13 $0.450 $0.520 3 438 500
Jan 15, 2016 $2.20 $2.35 $2.05 $2.34 50 000
Jan 14, 2016 $2.29 $2.44 $2.20 $2.34 129 900
Click to get the best stock tips daily for free!

About Eleven Biotherapeutics

Eleven Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of protein therapeutics to treat eye diseases primarily in the United States. The company develops its therapeutics through AMP-Rx, a proprietary protein engineering platform. Its lead product candidate is EBI-005, which has completed Phase III clinical trials for the treatment of patients with dry eye disease and allergic conjunctivitis. The compa... EBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT